Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Eri Okita"'
Autor:
Yutaro Ohno, Eri Okita, Mika Kawai-Uchida, Youji Shoukei, Kazuhiro Soshiroda, Tomoyuki Kanda, Shinichi Uchida
Publikováno v:
Journal of Pharmacological Sciences, Vol 152, Iss 3, Pp 193-199 (2023)
The adenosine A2A receptor antagonist/inverse agonist, KW-6356 has been shown to be effective in Parkinson's disease (PD) patients as monotherapy and as an adjunct therapy to L-3,4-dihydroxyphenylalanine (L-DOPA)/decarboxylase inhibitor. However, the
Externí odkaz:
https://doaj.org/article/c813e07e2733429a92c3bfbdfcba0ff4
Autor:
Yutaro Ohno, Eri Okita, Mika Kawai-Uchida, Naoko Fukuda, Youji Shoukei, Kazuhiro Soshiroda, Koji Yamada, Tomoyuki Kanda, Shinichi Uchida
Publikováno v:
European Journal of Pharmacology. 950:175773
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8b61b2b064610faf5e23c2d1da3cb644
https://doi.org/10.1016/j.ejphar.2023.175773
https://doi.org/10.1016/j.ejphar.2023.175773
Autor:
Tomoyuki Kanda, Eri Okita, Shin-ichi Uchida, Akihisa Mori, Mika Kawai-Uchida, Kazuhiro Soshiroda, Peter Jenner
Publikováno v:
European Journal of Pharmacology. 766:25-30
The adenosine A2A receptor antagonist, istradefylline improves motor function in patients with advanced Parkinson's disease (PD) optimally treated with a combination of L-DOPA and a dopamine agonist without increasing the risk of troublesome dyskines
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cbf514cff38b5be3877791e8a277574b
https://doi.org/10.1016/j.ejphar.2015.09.028
https://doi.org/10.1016/j.ejphar.2015.09.028
Autor:
Shin Ichi Uchida, Eri Okita, Kazuhiro Soshiroda, Akihisa Mori, Mika Kawai-Uchida, Tomoyuki Kanda, Peter Jenner
Publikováno v:
European Journal of Pharmacology. 747:160-165
The adenosine A2A receptor antagonist, istradefylline, enhances anti-parkinsonian activity in patients with advanced Parkinson׳s disease (PD) already treated with combinations of L-DOPA and dopamine agonist drugs but who are still exhibiting prolong
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::491f97ebd4e944b59d937334f3c60a5c
https://doi.org/10.1016/j.ejphar.2014.11.038
https://doi.org/10.1016/j.ejphar.2014.11.038
Autor:
Uemura, Yasunori1 (AUTHOR) yasunori.uemura.jm@kyowakirin.com, Kobayashi, Katsuya1 (AUTHOR)
Publikováno v:
Drug Delivery. Dec2019, Vol. 26 Issue 1, p803-811. 9p.
Autor:
Kawata, Takehisa1, Tokunaga, Shin1, Murai, Miki2, Masuda, Nami3, Haruyama, Waka1, Shoukei, Youji2, Hisada, Yutaka4, Yanagida, Tetsuya4, Miyazaki, Hiroshi4, Wada, Michihito5, Akizawa, Tadao6, Fukagawa, Masafumi7 fukagawa@tokai-u.jp
Publikováno v:
PLoS ONE. 4/3/2018, Vol. 13 Issue 4, p1-14. 14p.
Publikováno v:
Mediators of Inflammation. 2007, Vol. 2007, Special section p1-9. 9p. 4 Charts, 2 Graphs.
Publikováno v:
Inflammation Research; Aug2006, Vol. 55 Issue 8, p335-341, 7p